WallStSmart

Planet Image International Limited Class A Ordinary Shares (YIBO)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 67% more annual revenue ($258.90M vs $155.25M). YIBO leads profitability with a -5.3% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

YIBO

Avoid

32

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for YIBO.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

YIBO1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

YIBO4 concerns · Avg: 2.0/10
Market CapQuality
$73.45M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-14.4%2/10

ROE of -14.4% — below average capital efficiency

EPS GrowthGrowth
-41.4%2/10

Earnings declined 41.4%

Profit MarginProfitability
-5.3%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : YIBO

The strongest argument for YIBO centers on Price/Book. Revenue growth of 11.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : YIBO

The primary concerns for YIBO are Market Cap, Return on Equity, EPS Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

YIBO profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

YIBO carries more volatility with a beta of 3.62 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 32/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Planet Image International Limited Class A Ordinary Shares

TECHNOLOGY · COMPUTER HARDWARE · China

Planet Image International Limited (YIBO) is an innovative technology enterprise focused on delivering cutting-edge imaging solutions and comprehensive digital media services tailored to the entertainment, advertising, and e-commerce sectors. Leveraging advanced technology and a deep understanding of visual communication, YIBO addresses the growing need for high-quality digital content in a fast-paced market. With a talented workforce and strategic industry partnerships, the company is uniquely positioned to seize emerging opportunities and achieve sustainable growth in the dynamic visual marketing arena.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?